Leticia Gomes de Pontes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leticia Gomes de Pontes has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Lucilene Delazari dos Santos
Institute of Biotechnology, São Paulo State University (UNESP), Botucatu, SP 18607-440, Brazil
9 shared publications - Rui Seabra Ferreira Junior
São Paulo State University, Brazil; São Paulo State University, Brazil; São Paulo State University, Brazil
5 shared publications - Benedito Barraviera
São Paulo State University, Brazil; São Paulo State University, Brazil; São Paulo State University, Brazil
4 shared publications Nayara Rodrigues Vieira Cavassan
4 shared publications- Antonio Condino-Neto
Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
3 shared publications - Fausto Klabund Ferraris
Laboratório de Farmacologia, Instituto Nacional de Controle de Qualidade em Saúde Fundação Oswaldo Cruz Rio de Janeiro Brazil
3 shared publications
Latest Publications
- Open Access
- 17 March 2026
- Published by Brazilian Journals in Veredas do Direito
- Vol. 23 (5) , e5624
EDUCAÇÃO EM SAÚDE NA ATENÇÃO PRIMÁRIA: ESTRATÉGIAS EDUCATIVAS PARA PROMOÇÃO DA SAÚDE, PREVENÇÃO DE DOENÇAS E ENGAJAMENTO COMUNITÁRIO
A Atenção Primária à Saúde (APS) constitui a principal porta de entrada do sistema de saúde e desempenha papel central na coordenação do cuidado no território. Nesse contexto, a educação em saúde destaca-se como estratégia fundamental para promover o autocuidado, prevenir doenças e fortalecer a autonomia dos usuários. Este estudo tem como objetivo analisar o papel da educação em saúde na APS, com enfoque nas estratégias educativas voltadas à promoção da saúde, prevenção de doenças e fortalecimento do engajamento comunitário. Trata-se de uma revisão integrativa da literatura, realizada entre fevereiro e março de 2026, nas bases de dados MEDLINE e PubMed. Os resultados evidenciam que diferentes estratégias educativas contribuem para a promoção de hábitos saudáveis, fortalecimento do letramento em saúde, ampliação da participação social e qualificação das práticas profissionais. Conclui-se que a educação em saúde, quando desenvolvida de forma participativa e contextualizada, fortalece o engajamento comunitário e amplia a efetividade das ações de promoção da saúde na APS.
- 17 March 2026
- Published by Brazilian Journals in Veredas do Direito
- Vol. 23 (5) , e5624
Open AccessEDUCAÇÃO EM SAÚDE NA ATENÇÃO PRIMÁRIA: ESTRATÉGIAS EDUCATIVAS PARA PROMOÇÃO DA SAÚDE, PREVENÇÃO DE DOENÇAS E ENGAJAMENTO COMUNITÁRIO
A Atenção Primária à Saúde (APS) constitui a principal porta de entrada do sistema de saúde e desempenha papel central na coordenação do cuidado no território. Nesse contexto, a educação em saúde destaca-se como estratégia fundamental para promover o autocuidado, prevenir doenças e fortalecer a autonomia dos usuários. Este estudo tem como objetivo analisar o papel da educação em saúde na APS, com enfoque nas estratégias educativas voltadas à promoção da saúde, prevenção de doenças e fortalecimento do engajamento comunitário. Trata-se de uma revisão integrativa da literatura, realizada entre fevereiro e março de 2026, nas bases de dados MEDLINE e PubMed. Os resultados evidenciam que diferentes estratégias educativas contribuem para a promoção de hábitos saudáveis, fortalecimento do letramento em saúde, ampliação da participação social e qualificação das práticas profissionais. Conclui-se que a educação em saúde, quando desenvolvida de forma participativa e contextualizada, fortalece o engajamento comunitário e amplia a efetividade das ações de promoção da saúde na APS.
- Open Access
- 12 August 2024
- Published by MDPI AG in Preprints.org
Zika Virus in Extracellular Vesicles: Insights from Integrated Proteomic and Metabolomic Dependent Regulation of B Cell and PI3K/AKT/mTOR Signaling Pathway
Background; Cell-released extracellular vesicles (EVs) acting as 'metabolically and proteolytically active machines,' show potential in metabolomic and proteomic analysis of serum EVs. Despite diverse challenges, post-isolation omics characterization EVs offers crucial insights for effective analysis; (2) Methods: The research, involved children with Congenital Zika Syndrome, utilizing mass spectrometry for proteomics and GC-MS for metabolite identification. Vesicles were isolated using Izon qEV columns, quantified, and characterized by NTA and TEM. Data analysis employed Cytoescape/String and MetaboAnalyst, revealing variations in metabolic and proteomic profiles among groups through PCA and volcano plots. Proteins and Metabolite set enrichment analysis provided biologically meaningful patterns to enriched metabolites; (3) Results: Using molecular exclusion chromatography, the EVs were characterized, revealing size variations. Protein analysis identified 13 significantly altered proteins, including upregulated (e.g., AOM8Q6 - IGLC7) and downregulated (e.g., Q8TD86 - CALML6) ones. Metabolite analysis indicated involvement in the PI3K-AKT-mTOR pathway and suggested a role in Angiotensin inhibition in CZS+. Upstream of mTOR, Akt is the central signaling molecule in the PI3K pathway and plays critical roles in brain development as well as synaptic plasticity important for Zika Virus. The study provides insights into molecular mechanisms associated with CZS; (4) Conclusions: The study pinpointed valuable possible biomarkers, specifically proteins and metabolites, in Zika virus (ZIKV) infection. It stresses the necessity for broader investigations with advanced techniques to uncover molecular targets, potentially advancing pharmacological strategies.
- 12 August 2024
- Published by MDPI AG in Preprints.org
Open AccessZika Virus in Extracellular Vesicles: Insights from Integrated Proteomic and Metabolomic Dependent Regulation of B Cell and PI3K/AKT/mTOR Signaling Pathway
Background; Cell-released extracellular vesicles (EVs) acting as 'metabolically and proteolytically active machines,' show potential in metabolomic and proteomic analysis of serum EVs. Despite diverse challenges, post-isolation omics characterization EVs offers crucial insights for effective analysis; (2) Methods: The research, involved children with Congenital Zika Syndrome, utilizing mass spectrometry for proteomics and GC-MS for metabolite identification. Vesicles were isolated using Izon qEV columns, quantified, and characterized by NTA and TEM. Data analysis employed Cytoescape/String and MetaboAnalyst, revealing variations in metabolic and proteomic profiles among groups through PCA and volcano plots. Proteins and Metabolite set enrichment analysis provided biologically meaningful patterns to enriched metabolites; (3) Results: Using molecular exclusion chromatography, the EVs were characterized, revealing size variations. Protein analysis identified 13 significantly altered proteins, including upregulated (e.g., AOM8Q6 - IGLC7) and downregulated (e.g., Q8TD86 - CALML6) ones. Metabolite analysis indicated involvement in the PI3K-AKT-mTOR pathway and suggested a role in Angiotensin inhibition in CZS+. Upstream of mTOR, Akt is the central signaling molecule in the PI3K pathway and plays critical roles in brain development as well as synaptic plasticity important for Zika Virus. The study provides insights into molecular mechanisms associated with CZS; (4) Conclusions: The study pinpointed valuable possible biomarkers, specifically proteins and metabolites, in Zika virus (ZIKV) infection. It stresses the necessity for broader investigations with advanced techniques to uncover molecular targets, potentially advancing pharmacological strategies.
- Open Access
- 24 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6104
Photobiomodulation Reduces the Cytokine Storm Syndrome Associated with COVID-19 in the Zebrafish Model
Although the exact mechanism of the pathogenesis of coronavirus SARS-CoV-2 (COVID-19) is not fully understood, oxidative stress and the release of pro-inflammatory cytokines have been highlighted as playing a vital role in the pathogenesis of the disease. In this sense, alternative treatments are needed to reduce the level of inflammation caused by COVID-19. Therefore, this study aimed to investigate the potential effect of red photobiomodulation (PBM) as an attractive therapy to downregulate the cytokine storm caused by COVID-19 in a zebrafish model. RT-qPCR analyses and protein–protein interaction prediction among SARS-CoV-2 and Danio rerio proteins showed that recombinant Spike protein (rSpike) was responsible for generating systemic inflammatory processes with significantly increased levels of pro-inflammatory (il1b, il6, tnfa, and nfkbiab), oxidative stress (romo1) and energy metabolism (slc2a1a and coa1) mRNA markers, with a pattern similar to those observed in COVID-19 cases in humans. On the other hand, PBM treatment was able to decrease the mRNA levels of these pro-inflammatory and oxidative stress markers compared with rSpike in various tissues, promoting an anti-inflammatory response. Conversely, PBM promotes cellular and tissue repair of injured tissues and significantly increases the survival rate of rSpike-inoculated individuals. Additionally, metabolomics analysis showed that the most-impacted metabolic pathways between PBM and the rSpike treated groups were related to steroid metabolism, immune system, and lipid metabolism. Together, our findings suggest that the inflammatory process is an incisive feature of COVID-19 and red PBM can be used as a novel therapeutic agent for COVID-19 by regulating the inflammatory response. Nevertheless, the need for more clinical trials remains, and there is a significant gap to overcome before clinical trials can commence.
- 24 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6104
Open AccessPhotobiomodulation Reduces the Cytokine Storm Syndrome Associated with COVID-19 in the Zebrafish Model
Although the exact mechanism of the pathogenesis of coronavirus SARS-CoV-2 (COVID-19) is not fully understood, oxidative stress and the release of pro-inflammatory cytokines have been highlighted as playing a vital role in the pathogenesis of the disease. In this sense, alternative treatments are needed to reduce the level of inflammation caused by COVID-19. Therefore, this study aimed to investigate the potential effect of red photobiomodulation (PBM) as an attractive therapy to downregulate the cytokine storm caused by COVID-19 in a zebrafish model. RT-qPCR analyses and protein–protein interaction prediction among SARS-CoV-2 and Danio rerio proteins showed that recombinant Spike protein (rSpike) was responsible for generating systemic inflammatory processes with significantly increased levels of pro-inflammatory (il1b, il6, tnfa, and nfkbiab), oxidative stress (romo1) and energy metabolism (slc2a1a and coa1) mRNA markers, with a pattern similar to those observed in COVID-19 cases in humans. On the other hand, PBM treatment was able to decrease the mRNA levels of these pro-inflammatory and oxidative stress markers compared with rSpike in various tissues, promoting an anti-inflammatory response. Conversely, PBM promotes cellular and tissue repair of injured tissues and significantly increases the survival rate of rSpike-inoculated individuals. Additionally, metabolomics analysis showed that the most-impacted metabolic pathways between PBM and the rSpike treated groups were related to steroid metabolism, immune system, and lipid metabolism. Together, our findings suggest that the inflammatory process is an incisive feature of COVID-19 and red PBM can be used as a novel therapeutic agent for COVID-19 by regulating the inflammatory response. Nevertheless, the need for more clinical trials remains, and there is a significant gap to overcome before clinical trials can commence.
- Open Access
- 1 November 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (6) , 808-814
Estudo proteômico do melasma facial
- 1 November 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (6) , 808-814
Open AccessEstudo proteômico do melasma facial
- Open Access
- 10 September 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (6) , 808-814
Proteomic study of facial melasma
- 10 September 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (6) , 808-814
Open AccessProteomic study of facial melasma
- Open Access
- 9 September 2022
- Published by Springer Nature in Research Square
Photobiomodulation reduces the cytokine storm syndrome associated with Covid-19 in the zebrafish model
This work presents the first study showing how photobiomodulation (PBM) significantly increases cellular and tissue repair and elucidating the role of PBM with low-level laser as a possible new therapy in pathologies in COVID-19-associated cytokine storm syndrome from a zebrafish model. Our results demonstrate new strategies for treating SARS-COV-2 using PBM to modulate the expression of the genes and metabolites involved in inflammatory processes. These metabolic alterations show that the r-Spike led to disturbance in the energetic and inflammatory system, corroborating with the severe clinical conditions of human patients. Furthermore, PBM decreased the gene expression levels of pro-inflammatory cytokines such as il1b, il6, tnfa, and nfkbiab, and of factors involved in oxidative stress (romo1) and energy metabolism (slc2a1a, coa1), in various tissues, promoting an anti-inflammatory response. In summary, our study suggests that PBM may have a positive role in treating cytokine storm syndrome associated with COVID-19. PBM can significantly regulate the inflammatory response promoting cellular and tissue repair of injured tissues. This work suggests that PBM may have a positive role in treating COVID-19-associated cytokine storm syndrome. Nevertheless, the need for more clinical trials remains, and there is a significant gap to overcome before clinical trials.
- 9 September 2022
- Published by Springer Nature in Research Square
Open AccessPhotobiomodulation reduces the cytokine storm syndrome associated with Covid-19 in the zebrafish model
This work presents the first study showing how photobiomodulation (PBM) significantly increases cellular and tissue repair and elucidating the role of PBM with low-level laser as a possible new therapy in pathologies in COVID-19-associated cytokine storm syndrome from a zebrafish model. Our results demonstrate new strategies for treating SARS-COV-2 using PBM to modulate the expression of the genes and metabolites involved in inflammatory processes. These metabolic alterations show that the r-Spike led to disturbance in the energetic and inflammatory system, corroborating with the severe clinical conditions of human patients. Furthermore, PBM decreased the gene expression levels of pro-inflammatory cytokines such as il1b, il6, tnfa, and nfkbiab, and of factors involved in oxidative stress (romo1) and energy metabolism (slc2a1a, coa1), in various tissues, promoting an anti-inflammatory response. In summary, our study suggests that PBM may have a positive role in treating cytokine storm syndrome associated with COVID-19. PBM can significantly regulate the inflammatory response promoting cellular and tissue repair of injured tissues. This work suggests that PBM may have a positive role in treating COVID-19-associated cytokine storm syndrome. Nevertheless, the need for more clinical trials remains, and there is a significant gap to overcome before clinical trials.
- Open Access
Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reaction
Summary: Establishing new experimental animal models to assess the safety and immune response to the antigen used in the development of COVID-19 vaccine is an imperative issue. Based on the advantages of using zebrafish as a model in research, herein we suggest doing this to test the safety of the putative vaccine candidates and to study immune response against the virus. We produced a recombinant N-terminal fraction of the Spike SARS-CoV-2 protein and injected it into adult female zebrafish. The specimens generated humoral immunity and passed the antibodies to the eggs. However, they presented adverse reactions and inflammatory responses similar to severe cases of human COVID-19. The analysis of the structure and function of zebrafish and human Angiotensin-converting enzyme 2, the main human receptor for virus infection, presented remarkable sequence similarities. Moreover, bioinformatic analysis predicted protein-protein interaction of the Spike SARS-CoV-2 fragment and the Toll-like receptor pathway. It might help in the choice of future therapeutic pharmaceutical drugs to be studied. Based on the in vivo and in silico results presented here, we propose the zebrafish as a model for translational research into the safety of the vaccine and the immune response of the vertebrate organism to the SARS-CoV-2 virus.
Open AccessZebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reaction
Summary: Establishing new experimental animal models to assess the safety and immune response to the antigen used in the development of COVID-19 vaccine is an imperative issue. Based on the advantages of using zebrafish as a model in research, herein we suggest doing this to test the safety of the putative vaccine candidates and to study immune response against the virus. We produced a recombinant N-terminal fraction of the Spike SARS-CoV-2 protein and injected it into adult female zebrafish. The specimens generated humoral immunity and passed the antibodies to the eggs. However, they presented adverse reactions and inflammatory responses similar to severe cases of human COVID-19. The analysis of the structure and function of zebrafish and human Angiotensin-converting enzyme 2, the main human receptor for virus infection, presented remarkable sequence similarities. Moreover, bioinformatic analysis predicted protein-protein interaction of the Spike SARS-CoV-2 fragment and the Toll-like receptor pathway. It might help in the choice of future therapeutic pharmaceutical drugs to be studied. Based on the in vivo and in silico results presented here, we propose the zebrafish as a model for translational research into the safety of the vaccine and the immune response of the vertebrate organism to the SARS-CoV-2 virus.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 26, e20190067
Extracellular vesicles in infectious diseases caused by protozoan parasites in buffaloes
Keywords: Extracellular vesicles; Theileria spp.; Protozoan parasites; Nanoparticle tracking analysis; Proteomic analysis
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 26, e20190067
Open AccessExtracellular vesicles in infectious diseases caused by protozoan parasites in buffaloes
Keywords: Extracellular vesicles; Theileria spp.; Protozoan parasites; Nanoparticle tracking analysis; Proteomic analysis
- 1 February 2019
- Published by Elsevier in Journal of Proteomics
- Vol. 192, 280-290
Correlation between chronic venous ulcer exudate proteins and clinical profile: A cross-sectional study
- 1 February 2019
- Published by Elsevier in Journal of Proteomics
- Vol. 192, 280-290
Correlation between chronic venous ulcer exudate proteins and clinical profile: A cross-sectional study